TCM
Tang Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.08M | Hold |
850,000
| – | – | 0.11% | 116 |
|
2025
Q1 | $5.67M | Buy |
850,000
+100,000
| +13% | +$667K | 0.31% | 72 |
|
2024
Q4 | $9.43M | Hold |
750,000
| – | – | 0.62% | 46 |
|
2024
Q3 | $13.9M | Hold |
750,000
| – | – | 0.99% | 31 |
|
2024
Q2 | $16.1M | Buy |
750,000
+90,000
| +14% | +$1.94M | 1.64% | 17 |
|
2024
Q1 | $17.8M | Buy |
660,000
+410,000
| +164% | +$11M | 1.85% | 13 |
|
2023
Q4 | $7.49M | Buy |
250,000
+100,000
| +67% | +$3M | 0.69% | 39 |
|
2023
Q3 | $3.07M | Buy |
+150,000
| New | +$3.07M | 0.43% | 61 |
|
2022
Q4 | – | Sell |
-1,265,900
| Closed | -$20.2M | – | 102 |
|
2022
Q3 | $20.2M | Hold |
1,265,900
| – | – | 2.48% | 11 |
|
2022
Q2 | $17.4M | Hold |
1,265,900
| – | – | 2.64% | 12 |
|
2022
Q1 | $20.1M | Sell |
1,265,900
-1,265,900
| -50% | -$20.1M | 4.02% | 7 |
|
2021
Q4 | $55.3M | Hold |
2,531,800
| – | – | 11.12% | 3 |
|
2021
Q3 | $75.7M | Hold |
2,531,800
| – | – | 15.71% | 2 |
|
2021
Q2 | $112M | Hold |
2,531,800
| – | – | 22.32% | 2 |
|
2021
Q1 | $112M | Sell |
2,531,800
-433,685
| -15% | -$19.2M | 31.61% | 1 |
|
2020
Q4 | $163M | Hold |
2,965,485
| – | – | 24.83% | 2 |
|
2020
Q3 | $67.8M | Hold |
2,965,485
| – | – | 12.27% | 2 |
|
2020
Q2 | $62.1M | Hold |
2,965,485
| – | – | 6.03% | 3 |
|
2020
Q1 | $41.4M | Hold |
2,965,485
| – | – | 5.81% | 3 |
|
2019
Q4 | $67.5M | Hold |
2,965,485
| – | – | 8.06% | 3 |
|
2019
Q3 | $34.5M | Hold |
2,965,485
| – | – | 5.91% | 4 |
|
2019
Q2 | $44.5M | Hold |
2,965,485
| – | – | 6.01% | 4 |
|
2019
Q1 | $52M | Hold |
2,965,485
| – | – | 9.58% | 3 |
|
2018
Q4 | $43.9M | Hold |
2,965,485
| – | – | 10.08% | 3 |
|
2018
Q3 | $73M | Hold |
2,965,485
| – | – | 11.92% | 4 |
|
2018
Q2 | $58.2M | Hold |
2,965,485
| – | – | 7.38% | 4 |
|
2018
Q1 | $55.6M | Buy |
+2,965,485
| New | +$55.6M | 8.17% | 4 |
|